# Detection of Δ9-Tetrahydrocannabinol Impairment Using Resting-State fNIRS > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/functional-near-infrared-spectroscopy-thc-impairment/ > **Published:** 2026-03-25T21:43:40-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:39:13-04:00 > **Clinical Summary:** Explore functional near-infrared spectroscopy THC impairment detection as a promising objective method for cannabis intoxication assessment. --- CED Clinical Relevance  #91High Clinical Relevance  Strong evidence or policy relevance with direct clinical implications. 🔬 Evidence Watch  |  CED Clinic ThcImpairmentNeuroscienceSafetyRct Journal JAMA network open Study Type [Randomized Trial](https://cedclinic.com/cannabis-cannabinoids-therapeutic-applications-review/) Population Human participants Why This Matters Current methods for detecting [cannabis impairment](https://cedclinic.com/virginia-marijuana-impaired-driving-campaign/) rely heavily on subjective field sobriety tests that are prone to bias and may not accurately reflect actual functional impairment. This study explores whether objective neuroimaging technology could provide more reliable impairment detection, which has significant implications for workplace safety, driving regulations, and [clinical assessment](https://cedclinic.com/cannabis-use-disorder-neurobiology-attention-findings/). Clinical Summary This double-blind, randomized crossover trial examined 169 cannabis users who received either synthetic THC (5-80 mg) or placebo across separate visits. Researchers used functional near-infrared spectroscopy (fNIRS) to measure prefrontal cortex activity at baseline and at 100 and 200 minutes post-administration, comparing results to traditional field sobriety tests. The study found that fNIRS could detect THC-related brain changes with 76% accuracy, significantly outperforming field sobriety tests which showed high false positive rates. However, the technology still missed about one-quarter of impaired individuals, and the correlation between brain changes and functional impairment remains unclear. Dr. Caplan’s Take “While this represents meaningful progress toward objective impairment detection, I remain cautious about clinical translation. The 76% accuracy rate, while better than field sobriety tests, still leaves substantial room for both false positives and false negatives in real-world applications where the stakes are high.” Clinical Perspective 🧠 Clinicians should view this as promising early research rather than ready-for-practice technology. For patients using cannabis, this underscores the importance of understanding that impairment detection methods are evolving and that subjective assessment of one’s own impairment remains unreliable. The study reinforces the need for evidence-based approaches to [cannabis impairment](https://cedclinic.com/virginia-marijuana-impaired-driving-campaign/) rather than relying solely on traditional testing methods. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Detection%20of%20%CE%949-Tetrahydrocannabinol%20Impairment%20Using%20Resting-State%20Functional%20N...%20%40drcaplan&url=https%3A//pubmed.ncbi.nlm.nih.gov/41615687/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//pubmed.ncbi.nlm.nih.gov/41615687/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Detection%20of%20%CE%949-Tetrahydrocannabinol%20Impairment%20Using%20Resting-State%20Functional%20N...%20--%20via%20%40drcaplan.bsky.social%20https%3A//pubmed.ncbi.nlm.nih.gov/41615687/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://pubmed.ncbi.nlm.nih.gov/41615687/](https://pubmed.ncbi.nlm.nih.gov/41615687/) Table of Contents - [FAQ](#FAQ)[What is functional near-infrared spectroscopy (fNIRS) and how does it detect THC impairment?](#What_is_functional_near-infrared_spectroscopy_fNIRS_and_how_does_it_detect_THC_impairment) - [How accurate is fNIRS compared to traditional field sobriety tests for detecting cannabis impairment?](#How_accurate_is_fNIRS_compared_to_traditional_field_sobriety_tests_for_detecting_cannabis_impairment) - [What THC doses were tested and when can impairment be detected after consumption?](#What_THC_doses_were_tested_and_when_can_impairment_be_detected_after_consumption) - [Could fNIRS technology be used for roadside impairment testing in the future?](#Could_fNIRS_technology_be_used_for_roadside_impairment_testing_in_the_future) - [What are the clinical implications for healthcare providers treating cannabis users?](#What_are_the_clinical_implications_for_healthcare_providers_treating_cannabis_users) - [Related](#Related) ## FAQ #### What is functional near-infrared spectroscopy (fNIRS) and how does it detect THC impairment? fNIRS is a non-invasive brain imaging technology that measures blood flow and oxygenation in the prefrontal cortex during rest and cognitive tasks. This study found that fNIRS can detect THC-related changes in brain activity patterns that correlate with functional impairment, providing an objective measure of cannabis intoxication. #### How accurate is fNIRS compared to traditional field sobriety tests for detecting cannabis impairment? The study demonstrated that fNIRS showed greater accuracy and lower false positive rates compared to behavioral field sobriety tests (FSTs). This is significant because FSTs are subjective and prone to bias, while fNIRS provides objective neurological measurements of impairment. #### What THC doses were tested and when can impairment be detected after consumption? Participants received oral synthetic THC doses ranging from 5-80 mg or placebo in this controlled study. Brain scans were performed at approximately 100 and 200 minutes after administration, suggesting the technology can detect impairment during peak intoxication periods. #### Could fNIRS technology be used for roadside impairment testing in the future? While this study shows promising results for objective THC impairment detection, fNIRS currently requires specialized equipment and controlled conditions. Further research and technological development would be needed to create portable, roadside-compatible versions for law enforcement use. #### What are the clinical implications for healthcare providers treating cannabis users? This technology could help clinicians objectively assess cannabis impairment in medical settings, particularly for patients using [medical marijuana](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) or those presenting with suspected cannabis intoxication. It provides a scientific basis for understanding functional impairment beyond subjective behavioral assessments. {“@context”: “https://schema.org”, “@type”: “ScholarlyArticle”, “headline”: “Detection of \u03949-Tetrahydrocannabinol Impairment Using Resting-State Functional Near-Infrared Spectroscopy: A Randomized Clinical Trial.”, “url”: “https://pubmed.ncbi.nlm.nih.gov/41615687/”, “about”: “jama network open [randomized trial](https://cedclinic.com/cannabis-cannabinoids-therapeutic-applications-review/) detection”, “isPartOf”: “JAMA network open”} [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Federally Funded Study Reveals Marijuana Breathalyzer Breakthrough With 3-D Printed …](https://cedclinic.com/marijuana-breathalyzer-breakthrough-cannabis-detection/) Discover advancements in marijuana breathalyzer technology using 3-D printing that could revolutionize impairment detection. [Learn More](https://cedclinic.com/marijuana-breathalyzer-breakthrough-cannabis-detection/) [Potency-related effects of smoked cannabis on simulated driving performance: a randomized, controlled crossover trial.](https://cedclinic.com/cannabis-driving-impairment-effects-potency-safety/) Examine how different cannabis potencies affect driving performance in a controlled clinical trial setting. [Read Study](https://cedclinic.com/cannabis-driving-impairment-effects-potency-safety/) [FOX21 – A new study from Washington State University found cannabis use can impair and …](https://cedclinic.com/episodic-memory-cannabis-impairment-study/) Review findings from Washington State University on [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) and its impact on impairment and safety. [Explore Findings](https://cedclinic.com/episodic-memory-cannabis-impairment-study/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).